Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Polymer-free amphilimus-eluting stents comparable to drug-eluting stents—and offer a potential advantage

The team's evaluation included data from four different randomized controlled trials

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

Medtronic recalls a second directional atherectomy device due to risk of tip damage

There have been no incidents at this time, but the device is similar to another Medtronic solution that was recently recalled. 

What clinicians need to know about PCI, other revascularization techniques among women

The Society for Cardiovascular Angiography & Interventions has shared a new expert consensus statement that highlights sex-specific considerations associated with revascularization

Performing TAVR and TMVR during the same hospitalization may provide value

Patients undergoing both procedures at once tended to be sicker, but their risk of poor outcomes did not significantly increase. 

Catheter ablation 'significantly superior' to drug therapy when treating AFib

Researchers evaluated data from 13 different studies, sharing their findings in Annals of Palliative Medicine.